News Conference News TCT 2017 Experts Debate: Should Cerebral Protection Be Used for All TAVRs? Todd Neale November 09, 2017
Presentation TCT 2017 SENTINEL Design Features and Findings From the Meta-Analysis of Three Randomized Clinical Trials Presenter: Samir R. Kapadia October 31, 2017
Presentation TVT 2017 The SENTINEL Trial: Safety and Effectiveness of Cerebral Embolic Protection During TAVR Presenter: Axel Linke, Jeffrey J. Popma, Susheel Kodali June 15, 2017
News Conference News TVT 2017 Embolic Protection During TAVR Reduces Stroke Risk, Single-Center Study Shows Michael O'Riordan June 15, 2017
News Conference News TVT 2017 Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10 Shelley Wood June 12, 2017
News Daily News FDA Clears Sentinel Cerebral Protection Device for Use During TAVR Shelley Wood June 05, 2017
News Conference News EuroPCR 2017 Embolic Protection During TAVR Reduces Volume of Cerebral Lesions, but Clinical Benefit Not Evident: Meta-analysis Michael O'Riordan May 26, 2017
News Conference News ACC 2017 MitraClip Commercial Experience at 1 Year Sheds Light on Progress and Lingering Concerns L.A. McKeown March 27, 2017
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for February 2017 Shelley Wood March 01, 2017
News Daily News FDA Advisors Positive on Sentinel Cerebral Protection Device in TAVR Shelley Wood February 23, 2017
News Conference News ISET 2017 Forging Into the Future: Debating the Merits of TAVR in Younger, Futile, and Lower-Risk Patients Caitlin E. Cox February 06, 2017